SERA News and Press, Sera Prognostics Inc. From 04/24/25

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025 PR Newswire SALT LAKE CITY , April 24, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA), f...

2025-04-15 01:54:38 ET Summary Initiate Sera Prognostics with a Hold rating due to strong clinical data, but uncertain commercialization timeline for PreTRM Test. Stock volatility in 2025, with shares dropping from $7.50 to $3.25 due to various events, including a $50 million foll...

2025-03-19 19:13:13 ET Sera Prognostics Inc (SERA) Q4 2024 Earnings Conference Call March 19, 2025 05:00 PM ET Company Participants Peter DeNardo - IR, CapComm Partners Evguenia Lindgardt - President, CEO & Director Austin Aerts - CFO Conference Call Pa...

2025-03-19 16:13:20 ET More on Sera Prognostics Sera Prognostics dips 5%, prices $50M offering Sera Prognostics announces proposed public offering Seeking Alpha’s Quant Rating on Sera Prognostics Historical earnings data for Sera Prognostics Fi...

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN PR Newswire SALT LAKE CITY , March 19, 2025 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on im...

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , March 19, 2025 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing ...

Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2024-12-31 Worthington Steel Inc. (WS) is expected to report $0.67 for Q3 2025 General Mills Inc. (GIS) is expected to report $0.95 for Q3 2025 Talphera Inc. (TLPH) is expected to report for Q4 2024 Sensei Biot...

2025-03-12 23:56:16 ET Summary Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B, with 26 significant positions making up the majority of the portfolio. The top five holdings—Incyte, BeiGene, ACADIA Pharma, Madrigal Pharma, and Insmed—constitute app...

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025 PR Newswire SALT LAKE CITY , March 11, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA)...

Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference PR Newswire SALT LAKE CITY , Feb. 21, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by p...